Putnam Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-90,699
Closed -$2.7M 1112
2017
Q3
$2.7M Sell
90,699
-8,771
-9% -$268K 0.01% 681
2017
Q2
$3.3M Buy
99,470
+50,523
+103% +$1.59M 0.01% 630
2017
Q1
$1.45M Sell
48,947
-5,012
-9% -$137K ﹤0.01% 923
2016
Q4
$1.34M Sell
53,959
-16,116
-23% -$366K ﹤0.01% 937
2016
Q3
$1.58M Sell
70,075
-48,425
-41% -$1.14M ﹤0.01% 906
2016
Q2
$2.82M Buy
118,500
+36,646
+45% +$879K 0.01% 827
2016
Q1
$1.94M Buy
81,854
+1,688
+2% +$41.3K ﹤0.01% 959
2015
Q4
$2.23M Sell
80,166
-1,756
-2% -$44.1K 0.01% 948
2015
Q3
$1.69M Buy
81,922
+2,268
+3% +$57.4K ﹤0.01% 1035
2015
Q2
$2.04M Sell
79,654
-699
-0.9% -$17.7K ﹤0.01% 1061
2015
Q1
$2.03M Sell
80,353
-3,249
-4% -$79.2K ﹤0.01% 1051
2014
Q4
$1.99M Sell
83,602
-472
-0.6% -$10.4K ﹤0.01% 1029
2014
Q3
$1.65M Buy
84,074
+1,422
+2% +$29.3K ﹤0.01% 1074
2014
Q2
$1.98M Sell
82,652
-40,368
-33% -$974K ﹤0.01% 1031
2014
Q1
$3.27M Sell
123,020
-4,060
-3% -$96.5K 0.01% 919
2013
Q4
$2.56M Sell
127,080
-1,296
-1% -$24.1K 0.01% 978
2013
Q3
$2.24M Sell
128,376
-7,780
-6% -$135K 0.01% 1025
2013
Q2
$2.29M Buy
+136,156
New +$2.1M 0.01% 1011

Other funds holding GMED

Putnam Investments's GMED Position: Q4 2017 in Review

Putnam Investments sold out of Globus Medical (GMED) in Q4 2017, closing a stake of 90,699 shares — an estimated $2.7M sold.

Putnam Investments first reported a position in GMED in Q2 2013 and held it in 18 quarters. The position peaked at $3.3M in Q2 2017. 263 funds tracked by Wall St. Rank hold GMED as of Q4 2017.

  • Putnam Investments reported no remaining Globus Medical position as of Q4 2017 after selling out during the quarter.
  • Putnam Investments sold 90,699 Globus Medical shares in Q4 2017, an estimated $2.7M.
  • Putnam Investments first reported a position in Globus Medical in Q2 2013 and held it in 18 quarters.
  • Putnam Investments's Globus Medical position peaked at $3.3M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held Globus Medical as of Q4 2017.

Based on Putnam Investments's 13F filing for Q4 2017, filed 14 Feb 2018.